A New Vitamin D Analog, 2MD, Restores Trabecular and Cortical Bone Mass and Strength in Ovariectomized Rats With Established Osteopenia
Open Access
- 1 October 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 20 (10) , 1742-1755
- https://doi.org/10.1359/jbmr.050605
Abstract
An orally active, highly potent analog of 1α,25‐dihydroxyvitamin D3, 2MD, restores trabecular and cortical bone mass and strength by stimulating periosteal bone formation and decreasing trabecular bone resorption in OVX rats with established osteopenia. Introduction: The purposes of this study were to determine the effects of long‐term treatment with 2‐methylene‐19‐nor‐(20S)‐1α,25(OH)2D3 (2MD) on restoring bone mass and bone strength in ovariectomized (OVX) rats with established osteopenia and 2MD effects on bone formation and bone resorption on trabecular and cortical bone surfaces. Materials and Methods: Sprague‐Dawley female rats were sham‐operated (sham) or OVX at 4 months of age. Beginning at 8 weeks after OVX, OVX rats were orally dosed with 2MD at 0.5, 1, 2.5, 5, or 10 ng/kg/day for 16 weeks. Serum calcium was measured at 6, 13, and 16 weeks after treatment, and bone mass and structure, bone formation, bone resorption, and bone strength were determined at the end of the study. Results: Serum calcium did not change significantly with 2MD at 0.5 or 1 ng/kg/day, whereas it significantly increased at 2.5, 5, or 10 ng/kg/day. 2MD significantly and dose‐dependently increased total body BMD, total BMC, and stiffness of femoral shaft (FS), maximal load and stiffness of femoral neck, and toughness of the fifth lumbar vertebral body (L5) at all doses compared with OVX controls. In 2MD‐treated OVX rats, there was a dose‐dependent increase in total BMD and total BMC of the distal femoral metaphysis (DFM), trabecular bone volume of L3, ultimate strength and stiffness of L5, and maximal load of FS compared with OVX controls at dosages ≥1 ng/kg/day. At dosages >2.5 ng/kg/day, most of the bone mass and bone strength related parameters were significantly higher in 2MD‐treated OVX rats compared with sham controls. Bone histomorphometric analysis of L3 showed dose‐dependent decreases in osteoclast number and osteoclast surface on trabecular bone surface and a dose‐dependent increase in periosteal bone formation associated with 2MD treatment. Conclusions: 2MD not only restored both trabecular and cortical bone mass but also added bone to the osteopenic OVX rats beyond that of sham controls by stimulating bone formation on the periosteal surface and decreasing bone resorption on the trabecular surface. 2MD increased bone mass and strength at doses that did not induced hypercalcemia.Keywords
This publication has 44 references indexed in Scilit:
- A new active vitamin D analog, ED‐71, causes increase in bone mass with preferential effects on bone in osteoporotic patientsJournal of Cellular Biochemistry, 2003
- Evidence for tissue‐ and cell‐type selective activation of the vitamin D receptor by Ro‐26‐9228, a noncalcemic analog of vitamin D3Journal of Cellular Biochemistry, 2003
- Role of the vitamin D‐endocrine system in the pathophysiology of postmenopausal osteoporosisJournal of Cellular Biochemistry, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Lasofoxifene (CP-336,156) Protects Against the Age-Related Changes in Bone Mass, Bone Strength, and Total Serum Cholesterol in Intact Aged Male RatsJournal of Bone and Mineral Research, 2001
- Alfacalcidol Inhibits Bone Resorption and Stimulates Formation in an Ovariectomized Rat Model of Osteoporosis: Distinct Actions from EstrogenJournal of Bone and Mineral Research, 2000
- New 1α,25-Dihydroxy-19-norvitamin D3 Compounds of High Biological Activity: Synthesis and Biological Evaluation of 2-Hydroxymethyl, 2-Methyl, and 2-Methylene AnaloguesJournal of Medicinal Chemistry, 1998
- Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized ratsBone, 1995
- Treatment of Postmenopausal Osteoporosis with Calcitriol or CalciumNew England Journal of Medicine, 1992
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987